Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ZANDD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
eP4183421A1 23C2 Her2-2-DXD
|
|||||
| Synonyms |
23C2 Her2-2-DXD
Click to Show/Hide
|
|||||
| Organization |
Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
5.7
|
|||||
| Structure |
|
|||||
| Antibody Name |
23C2 Her2-2
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
EP4183421A1+Trastuzumab-DXD+Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||